SEC 'Shadow Trading' Victory Could Bring DOJ Knocking https://www.law360.com/compliance/articles/1822980?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-09&read_main=1&nlsidx=0&nlaidx=1 By Jessica Corso Now that the U.S. Securities and Exchange Commission has convinced a jury that a pharmaceutical executive committed insider trading by purchasing a competitor's stock in a practice often referred to as "shadow trading," attorneys say federal prosecutors might be tempted to dip their toe into the waters of the previously untested legal theory. Read full article » https://www.law360.com/compliance/articles/1822980?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-09&read_more=1&nlsidx=0&nlaidx=1 | Save to favorites » https://www.law360.com/compliance/articles/1822980?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-09&read_later=1&nlsidx=0&nlaidx=1